LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 33

Search options

  1. Article: Inhibition of the activated sludge-associated enzyme phosphatase by transition metal oxyanions.

    Böger, Beatriz / Wacht, Marion / Leuck, Michaela / de O Vilhena, Raquel / Riese, Maria / Fischer, Klaus

    Water science and technology : a journal of the International Association on Water Pollution Research

    2021  Volume 83, Issue 11, Page(s) 2629–2639

    Abstract: Organic esters of phosphoric acid and other organophosphorous compounds are enzymatically hydrolyzed during wastewater treatment by microbial phosphoesterases, especially by phosphomonoesterase (phosphatase). For physiological reasons, the enzyme is ... ...

    Abstract Organic esters of phosphoric acid and other organophosphorous compounds are enzymatically hydrolyzed during wastewater treatment by microbial phosphoesterases, especially by phosphomonoesterase (phosphatase). For physiological reasons, the enzyme is inhibited by its main inorganic reaction product, ortho-phosphate. It is known that oxyanions of transition metals, resembling the molecular topology of ortho-phosphate, e.g. vanadate and tungstate, are more potent inhibitors for microbial alkaline phosphatase than phosphate. To proof this effect for activated sludge, a multitude of samples from a communal wastewater treatment plant was exposed at pH values from 7.00 to 8.50 to tungstate, vanadate, and molybdate. Inhibition effects were determined by a sensitive fluorimetric microplate assay and characteristic parameters (IC
    MeSH term(s) Kinetics ; Molybdenum ; Phosphates ; Phosphoric Monoester Hydrolases ; Sewage ; Vanadates
    Chemical Substances Phosphates ; Sewage ; Vanadates (3WHH0066W5) ; Molybdenum (81AH48963U) ; Phosphoric Monoester Hydrolases (EC 3.1.3.2)
    Language English
    Publishing date 2021-06-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 764273-8
    ISSN 1996-9732 ; 0273-1223
    ISSN (online) 1996-9732
    ISSN 0273-1223
    DOI 10.2166/wst.2021.172
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A Systematic Review and Meta-analyses of Longitudinal Studies on Drug Treatments for Gaucher Disease.

    Leonart, Letícia Paula / Fachi, Mariana M / Böger, Beatriz / Silva, Mariana Ribeiro da / Szpak, Renata / Lombardi, Natália Fracaro / Pedroso, Maria Lucia Alves / Pontarolo, Roberto

    The Annals of pharmacotherapy

    2022  Volume 57, Issue 3, Page(s) 267–282

    Abstract: Objective: Gaucher disease (GD) is a rare disorder linked to the absence/deficiency of glucocerebrosidase. GD can be treated by enzyme replacement therapy (ERT) and substrate reduction therapy (SRT). The aim of this systematic review (SR) is to assess ... ...

    Abstract Objective: Gaucher disease (GD) is a rare disorder linked to the absence/deficiency of glucocerebrosidase. GD can be treated by enzyme replacement therapy (ERT) and substrate reduction therapy (SRT). The aim of this systematic review (SR) is to assess the effectiveness of drugs used for GD treatment.
    Data sources: Searches were conducted in PubMed and Scopus, in April 2021. The search strategies encompassed the name of the disease and of the drug treatments. Manual search was also conducted.
    Study selection and data extraction: Observational and interventional longitudinal studies evaluating ERT and SRT for GD were included. Single mean meta-analyses were conducted for each drug using R.
    Data synthesis: The initial search retrieved 2246 articles after duplicates were removed. Following screening and eligibility assessment, 68 reports were included. The studies evaluated imiglucerase, velaglucerase alfa, taliglucerase alfa, miglustat, and eliglustat. The results showed that ERT is effective as a treatment in both naïve and experienced patients. Miglustat did not significantly improve blood outcomes in naïve patients and resulted in a decrease in the platelet levels of experienced patients. Eliglustat was mainly assessed for experienced patients and resulted in stable outcome values.
    Relevance to patient care and clinical practice: This extensive SR confirms the effectiveness of GD treatments in short- and long-term follow-ups.
    Conclusions: The results were favorable for all ERTs and for eliglustat. Based on the assessed evidence, miglustat did not achieved expressive results. However, all evidence should be interpreted considering its limitations and does not replace well-conducted randomized trials.
    MeSH term(s) Humans ; Gaucher Disease/drug therapy ; Gaucher Disease/diagnosis ; Glucosylceramidase/therapeutic use ; Glucosylceramidase/adverse effects ; 1-Deoxynojirimycin/therapeutic use ; Blood Platelets ; Enzyme Replacement Therapy/methods
    Chemical Substances miglustat (ADN3S497AZ) ; Glucosylceramidase (EC 3.2.1.45) ; 1-Deoxynojirimycin (19130-96-2)
    Language English
    Publishing date 2022-07-11
    Publishing country United States
    Document type Meta-Analysis ; Systematic Review ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1101370-9
    ISSN 1542-6270 ; 1060-0280
    ISSN (online) 1542-6270
    ISSN 1060-0280
    DOI 10.1177/10600280221108443
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses.

    Domingos, Eric L / Vilhena, Raquel O / Santos, Josiane M M F / Fachi, Mariana M / Böger, Beatriz / Adam, Livia M / Tonin, Fernanda S / Pontarolo, Roberto

    International journal of antimicrobial agents

    2022  Volume 60, Issue 2, Page(s) 106614

    Abstract: Aim: Invasive candidiasis is the most common fungal infection in patients attending health services and is associated with high mortality rates and prolonged hospital stay. The aim of this review was to evaluate and compare efficacy and safety of ... ...

    Abstract Aim: Invasive candidiasis is the most common fungal infection in patients attending health services and is associated with high mortality rates and prolonged hospital stay. The aim of this review was to evaluate and compare efficacy and safety of antifungal agents for the treatment of candidemia.
    Methods: A systematic review with network meta-analysis (NMA), surface under the cumulative ranking analysis (SUCRA) and stochastic multicriteria acceptability analyses (SMAA) was performed (PROSPERO-CRD42020149264). Searches were conducted in PubMed and Scopus (Nov-2021). Randomised controlled trials evaluating the effect of oral antifungals (any dose or regimen) on mycological cure, discontinuation rates and adverse events were included.
    Results: Overall, 13 trials (n=3632) were analysed. There were no significant differences between therapies for the efficacy outcomes; however, caspofungin (50-150 mg), rezafungin (200-400 mg) and micafungin (100-150 mg) had higher rates of clinical and mycological responses (SUCRA overall response >60%) and were considered the most promising therapies. Fluconazole (400 mg) rated worst for overall response (17%). Rezafungin (200-400 mg) and micafungin (100 mg) were associated with lower discontinuation rates (<40%). Conventional amphotericin B (0.6-0.7 mg/kg) was more likely to be discontinued (odds ratio [OR] 0.08; 95% credibility interval [CrI] 0.00-0.95 vs. caspofungin 150 mg) and may impair liver function (87%).
    Conclusion: Echinocandins are recommended as first-line treatments for invasive candidiasis following a priority order of caspofungin then micafungin. Rezafungin, an echinocandin under development, represents a potential option that should be further investigated. Azoles and liposomal amphotericin B can be used as second-line treatments in cases of fungal resistance or hypersensitivity.
    MeSH term(s) Antifungal Agents/therapeutic use ; Candidemia/drug therapy ; Candidiasis, Invasive/drug therapy ; Caspofungin/therapeutic use ; Echinocandins/therapeutic use ; Humans ; Lipopeptides/therapeutic use ; Micafungin/therapeutic use ; Network Meta-Analysis
    Chemical Substances Antifungal Agents ; Echinocandins ; Lipopeptides ; Caspofungin (F0XDI6ZL63) ; Micafungin (R10H71BSWG)
    Language English
    Publishing date 2022-06-09
    Publishing country Netherlands
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 1093977-5
    ISSN 1872-7913 ; 0924-8579
    ISSN (online) 1872-7913
    ISSN 0924-8579
    DOI 10.1016/j.ijantimicag.2022.106614
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19.

    Böger, Beatriz / Fachi, Mariana M / Vilhena, Raquel O / Cobre, Alexandre F / Tonin, Fernanda S / Pontarolo, Roberto

    American journal of infection control

    2020  Volume 49, Issue 1, Page(s) 21–29

    Abstract: Objective: To collate the evidence on the accuracy parameters of all available diagnostic methods for detecting SARS-CoV-2.: Methods: A systematic review with meta-analysis was performed. Searches were conducted in Pubmed and Scopus (April 2020). ... ...

    Abstract Objective: To collate the evidence on the accuracy parameters of all available diagnostic methods for detecting SARS-CoV-2.
    Methods: A systematic review with meta-analysis was performed. Searches were conducted in Pubmed and Scopus (April 2020). Studies reporting data on sensitivity or specificity of diagnostic tests for COVID-19 using any human biological sample were included.
    Results: Sixteen studies were evaluated. Meta-analysis showed that computed tomography has high sensitivity (91.9% [89.8%-93.7%]), but low specificity (25.1% [21.0%-29.5%]). The combination of IgM and IgG antibodies demonstrated promising results for both parameters (84.5% [82.2%-86.6%]; 91.6% [86.0%-95.4%], respectively). For RT-PCR tests, rectal stools/swab, urine, and plasma were less sensitive while sputum (97.2% [90.3%-99.7%]) presented higher sensitivity for detecting the virus.
    Conclusions: RT-PCR remains the gold standard for the diagnosis of COVID-19 in sputum samples. However, the combination of different diagnostic tests is highly recommended to achieve adequate sensitivity and specificity.
    MeSH term(s) Antibodies, Viral/immunology ; COVID-19/diagnosis ; COVID-19/immunology ; COVID-19 Nucleic Acid Testing ; COVID-19 Serological Testing ; COVID-19 Testing ; Coronavirus Envelope Proteins/genetics ; Coronavirus RNA-Dependent RNA Polymerase/genetics ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Lung/diagnostic imaging ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; Sensitivity and Specificity ; Tomography, X-Ray Computed
    Chemical Substances Antibodies, Viral ; Coronavirus Envelope Proteins ; Immunoglobulin G ; Immunoglobulin M ; envelope protein, SARS-CoV-2 ; Coronavirus RNA-Dependent RNA Polymerase (EC 2.7.7.48) ; NSP12 protein, SARS-CoV-2 (EC 2.7.7.48)
    Keywords covid19
    Language English
    Publishing date 2020-07-10
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 392362-9
    ISSN 1527-3296 ; 0196-6553
    ISSN (online) 1527-3296
    ISSN 0196-6553
    DOI 10.1016/j.ajic.2020.07.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Sensitivity and specificity of multibacillary and paucibacillary leprosy laboratory tests: A systematic review and meta-analysis.

    Torres, Reginaldo Thuler / Fachi, Mariana Millan / Böger, Beatriz / Marson, Breno Maurício / Ferreira, Vinicíus Lins / Pontarolo, Roberto / Guimarães, Thais Martins

    Diagnostic microbiology and infectious disease

    2021  Volume 100, Issue 2, Page(s) 115337

    Abstract: This systematic review (number register: CRD42018112736) was performed to compare the sensitivity and specificity of leprosy diagnostic methods. The search was conducted in 3 electronic databases in January 2021. Studies evaluating leprosy diagnostic ... ...

    Abstract This systematic review (number register: CRD42018112736) was performed to compare the sensitivity and specificity of leprosy diagnostic methods. The search was conducted in 3 electronic databases in January 2021. Studies evaluating leprosy diagnostic tests were included according the eligibility criteria. Meta-analysis was performed to calculate the sensibility and specificity of the groups. We included 36 studies. The test sensitivity for paucibacillary patients was 0.31 (95%CI: 0.29-0.33) and the specificity was 0.92 (95%CI: 0.92-0.93). In multibacillary patients, the sensitivity was 0.78 (95%CI: 0.77-0.80) and specificity was 0.92 (95%CI: 0.92-0.93). Comparing the sensitivity and specificity of the different techniques included, it should be noted that polymerase chain reaction (PCR) test presented the highest sensitivity for paucibacillary patients, while the western blot technique showed the highest sensitivity for multibacillary patients. However, further studies are needed to optimise the diagnosis of leprosy, requiring research with a larger number of samples and more uniform protocols.
    MeSH term(s) Blotting, Western/methods ; Leprosy, Multibacillary/diagnosis ; Leprosy, Paucibacillary/diagnosis ; Polymerase Chain Reaction/methods ; Sensitivity and Specificity
    Language English
    Publishing date 2021-02-03
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 604920-5
    ISSN 1879-0070 ; 0732-8893
    ISSN (online) 1879-0070
    ISSN 0732-8893
    DOI 10.1016/j.diagmicrobio.2021.115337
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: MACHINE LEARNING-BASED VIRTUAL SCREENING, MOLECULAR DOCKING, DRUG-LIKENESS, PHARMACOKINETICS AND TOXICITY ANALYSES TO IDENTIFY NEW NATURAL INHIBITORS OF THE GLYCOPROTEIN SPIKE (S1) of SARS-CoV-2

    Alexandre de F. Cobre / Beatriz Böger / Mariana M. Fachi / Carlos A. Ehrenfried / Dile P. Stremel / Eduardo B. De Melo / Fernanda S. Tonin / Roberto Pontarolo

    Química Nova, Vol 46, Iss 5, Pp 450-

    2023  Volume 459

    Abstract: To identify natural bioactive compounds (NBCs) as potential inhibitors of spike (S1) by means of in silico assays. NBCs with previously proven biological in vitro activity were obtained from the ZINC database and analyzed through virtual screening and ... ...

    Abstract To identify natural bioactive compounds (NBCs) as potential inhibitors of spike (S1) by means of in silico assays. NBCs with previously proven biological in vitro activity were obtained from the ZINC database and analyzed through virtual screening and molecular docking to identify those with higher affinity to the spike protein. Eight machine learning models were used to validate the results: Principal Component Analysis (PCA), Artificial Neural Network (ANN), Support Vector Machine (SVM), k-Nearest Neighbors (KNN), Partial Least Squares-Discriminant Analysis (PLS-DA), Gradient Boosted Tree Discriminant Analysis (XGBoostDA), Soft Independent Modelling of Class Analogies (SIMCA) and Logistic Regression Discriminate Analysis (LREG). Selected NBCs were submitted to drug-likeness prediction using Lipinski’s and Veber’s rule of five. A prediction of pharmacokinetic parameters and toxicity was also performed (ADMET). Antivirals currently used for COVID-19 (remdesivir and molnupiravir) were used as a comparator. A total of 170,906 compounds were analyzed. Of these, 34 showed greater affinity with the S1 (affinity energy < -7 kcal mol-1). Most of these compounds belonged to the class of coumarins (benzopyrones), presenting a benzene ring fused to a lactone (group of heterosides). The PLS-DA model was able to reproduce the results of the virtual screening and molecular docking (accuracy of 97.0%). Of the 34 compounds, only NBC5 (feselol), NBC14, NBC15 and NBC27 had better results in ADMET predictions. These had similar binding affinity to S1 when compared to remdesivir and molnupirvir. Feselol and three other NBCs were the most promising candidates for treating COVID-19. In vitro and in vivo studies are needed to confirm these findings.
    Keywords Chemistry ; QD1-999
    Subject code 540
    Language English
    Publishing date 2023-06-01T00:00:00Z
    Publisher Sociedade Brasileira de Química
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Legal demands of the tiotropium bromide for treatment of chronic obstructive pulmonary disease and their financial impact for the State of Paraná, Brazil.

    Szpak, Renata / Strapasson, Giovanna Chipon / Böger, Beatriz / Rattmann, Yanna Dantas / Gomes, Eliane Carneiro

    Einstein (Sao Paulo, Brazil)

    2019  Volume 18, Page(s) eGS4442

    Abstract: Objective: To analyze the legal demands of tiotropium bromide to treat chronic obstructive pulmonary disease.: Methods: We included secondary data from the pharmaceutical care management systems made available by the Paraná State Drug Center.: ... ...

    Abstract Objective: To analyze the legal demands of tiotropium bromide to treat chronic obstructive pulmonary disease.
    Methods: We included secondary data from the pharmaceutical care management systems made available by the Paraná State Drug Center.
    Results: Public interest civil action and ordinary procedures, among others, were the most common used by the patients to obtain the medicine. Two Health Centers in Paraná (Londrina and Umuarama) concentrated more than 50% of the actions. The most common specialty of physicians who prescribed (33.8%) was pulmonology. There is a small financial impact of tiotropium bromide on general costs with medicines of the Paraná State Drug Center. However, a significant individual financial impact was observed because one unit of the medicine represents 38% of the Brazilian minimum wage.
    Conclusion: Our study highlights the need of incorporating this medicine in the class of long-acting anticholinergic bronchodilator in the Brazilian public health system.
    MeSH term(s) Brazil ; Bronchodilator Agents/economics ; Drugs, Essential/economics ; Drugs, Essential/supply & distribution ; Health Services Accessibility/economics ; Health Services Accessibility/legislation & jurisprudence ; Health Services Accessibility/trends ; Health Services Needs and Demand/economics ; Health Services Needs and Demand/legislation & jurisprudence ; Health Services Needs and Demand/trends ; Humans ; Judicial Role ; National Health Programs ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Pulmonary Disease, Chronic Obstructive/economics ; Retrospective Studies ; Statistics, Nonparametric ; Time Factors ; Tiotropium Bromide/economics
    Chemical Substances Bronchodilator Agents ; Drugs, Essential ; Tiotropium Bromide (XX112XZP0J)
    Language Portuguese
    Publishing date 2019-09-26
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 2418293-X
    ISSN 2317-6385 ; 1679-4508
    ISSN (online) 2317-6385
    ISSN 1679-4508
    DOI 10.31744/einstein_journal/2020GS4442
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Systematic review with network meta-analysis on the treatments for latent tuberculosis infection in children and adolescents.

    Santos, Josiane M / Fachi, Mariana M / Beraldi-Magalhães, Francisco / Böger, Beatriz / Junker, Allan M / Domingos, Eric L / Imazu, Priscila / Fernandez-Llimos, Fernando / Tonin, Fernanda S / Pontarolo, Roberto

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

    2022  Volume 28, Issue 12, Page(s) 1645–1653

    Abstract: Background: We aimed to synthesize the evidence on the efficacy and safety of different treatment regimens for latent tuberculosis infection (LTBI) in children and adolescents.: Methods: A systematic review with network meta-analysis was performed ( ... ...

    Abstract Background: We aimed to synthesize the evidence on the efficacy and safety of different treatment regimens for latent tuberculosis infection (LTBI) in children and adolescents.
    Methods: A systematic review with network meta-analysis was performed (CRD142933). Searches were conducted in Pubmed and Scopus (Nov-2021). Randomized controlled trials comparing treatments for LTBI (patients up to 15 years), and reporting data on the incidence of the disease, death or adverse events were included. Networks using the Bayesian framework were built for each outcome of interest. Results were reported as odds ratio (OR) with 95% credibility intervals (CrI). Rank probabilities were calculated via the surface under the cumulative ranking analysis (SUCRA) (Addis-v.1.16.8). GRADE approach was used to rate evidence's certainty.
    Results: Seven trials (n = 8696 patients) were included. Placebo was significantly associated with a higher incidence of tuberculosis compared to all active therapies. Combinations of isoniazid (15-25 mg/kg/week) plus rifapentine (300-900 mg/week), followed by isoniazid plus rifampicin (10 mg/kg/day) were ranked as best approaches with lower probabilities of disease incidence (10% and 19.5%, respectively in SUCRA) and death (20%). Higher doses of isoniazid monotherapy were significantly associated to more deaths (OR 18.28, 95% ICr [1.02, 48.60] of 4-6 mg/kg/day vs. 10 mg/kg/3x per week).
    Conclusions: Combined therapies of isoniazid plus rifapentine or rifampicin for short-term periods should be used as the first-line approach for treating LTBI in children and adolescents. The use of long-term isoniazid as monotherapy and at higher doses should be avoided for this population.
    MeSH term(s) Adolescent ; Antitubercular Agents/adverse effects ; Bayes Theorem ; Child ; Humans ; Isoniazid/adverse effects ; Latent Tuberculosis/drug therapy ; Latent Tuberculosis/epidemiology ; Network Meta-Analysis ; Rifampin/therapeutic use
    Chemical Substances Antitubercular Agents ; Isoniazid (V83O1VOZ8L) ; Rifampin (VJT6J7R4TR)
    Language English
    Publishing date 2022-09-06
    Publishing country Netherlands
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 1355399-9
    ISSN 1437-7780 ; 1341-321X
    ISSN (online) 1437-7780
    ISSN 1341-321X
    DOI 10.1016/j.jiac.2022.08.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: A multivariate analysis of risk factors associated with death by Covid-19 in the USA, Italy, Spain, and Germany.

    Cobre, Alexandre de Fátima / Böger, Beatriz / Vilhena, Raquel de Oliveira / Fachi, Mariana Millan / Dos Santos, Josiane Marlei Muller Fernandes / Tonin, Fernanda Stumpf

    Zeitschrift fur Gesundheitswissenschaften = Journal of public health

    2020  Volume 30, Issue 5, Page(s) 1189–1195

    Abstract: Aim: Our aim was to investigate the risk factors associated with death from COVID-19 in four countries: The USA, Italy, Spain, and Germany.: Subject and methods: We used data from the Institute for Health Metrics and Evaluation with projection ... ...

    Abstract Aim: Our aim was to investigate the risk factors associated with death from COVID-19 in four countries: The USA, Italy, Spain, and Germany.
    Subject and methods: We used data from the Institute for Health Metrics and Evaluation with projection information from January-August 2020. A multivariate analysis of logistic regression was performed. The following factors were analyzed (per day): number of beds needed for the hospital services, number of intensive care units (ICU) beds required, number of ventilation devices, number of both hospital and ICU admissions due to COVID-19. Nagelkerke's R
    Results: Among the evaluated countries, Italy presented greater need for ICU beds/day (≤ 98; OR = 2315.122; CI 95% [334.767-16,503.502];
    Conclusions: Further investments in hospitals' infrastructure, as well as the development of innovative devices for patient's ventilation, are paramount to fight the pandemic in the USA, Italy, Spain, and Germany.
    Keywords covid19
    Language English
    Publishing date 2020-10-19
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 1149070-6
    ISSN 2198-1833 ; 0943-1853
    ISSN 2198-1833 ; 0943-1853
    DOI 10.1007/s10389-020-01397-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19

    Böger, Beatriz / Fachi, Mariana M. / Vilhena, Raquel O. / Cobre, Alexandre F. / Tonin, Fernanda S. / Pontarolo, Roberto

    American Journal of Infection Control ; ISSN 0196-6553

    2020  

    Keywords Public Health, Environmental and Occupational Health ; Health Policy ; Epidemiology ; Infectious Diseases ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.ajic.2020.07.011
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top